Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
Several people detained in India's Gen Z-led protests against voter roll changes
Saudi Arabia says shrapnel from intercepted ballistic missile in Asir injures one
Israeli strike kills five in Gaza, health officials say
Nine injured in Australia as car crashes into crowd north of Sydney
India's 'cockroach' youth party to protest, demand poll chief's resignation
